Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-24-000576
Filing Date
2024-11-12
Accepted
2024-11-12 11:34:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3301
  Complete submission text file 0002007317-24-000576.txt   4881
Mailing Address C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Curran Terrie (Reporting) CIK: 0001690298 (see all company filings)

Type: 144

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Subject) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39186 | Film No.: 241445579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)